NY-AQARA
19.10.2021 15:02:06 CEST | Business Wire | Press release
Aqara, a leading provider of smart home products, announced the launch of its Professional Partners Program for smart home installers and integrators. Utilizing Aqara’s decade-long experience in the smart home industry and its comprehensive suite of smart home products, advanced technologies, solutions, and tools, the Professional Partners Program aims to support professional installers in enhancing their service offerings and growing their businesses. The Program also welcomes the broader professional community, such as shading control installers, smart lock locksmiths, home theater installers, interior designers and electricians, to join the Aqara partner network.
With years of experience in offering high-quality products to global consumers, Aqara now seeks to join forces with the professional community to boost adoption of the smart home technology worldwide. As part of Aqara Partners Program, participants will enjoy:
- Priority access to new Aqara products
- Special promotional pricing on certain products
- Comprehensive product training support and resources
- Opportunity to connect with interested Aqara users in local areas
- Marketing support
Starting in October 2021, Aqara has launched an exclusive Smart Roller Shade Controller Package as the first promotional event within the Professional Partners Program for a limited time. The Smart Roller Shade Controller is the global version of Aqara’s most popular roller shade motor, which is designed to automate a variety of roller blinds and even projector screens. Bound with an Aqara hub, the controller allows roller shades to be controlled by mobiles, voice commands (Apple Siri, Google Assistant, Yandex Alice, Naver Clova, etc.), pre-set schedules, and via home automations in which roller shades could be triggered by illumination condition, human motion, room temperature, etc.
To learn more about the Professional Partners Program or register for the Smart Roller Shade Controller Package, please visit our website .
About Aqara
Founded in 2016, Aqara is a leading smart home provider with offices in New York and Shenzhen. The Company provides comprehensive smart home products and solutions that are beautifully designed, long-lasting, and easy to use. Products range from a variety of smart sensors to switches, curtain controllers, and smart door locks. Over the last few years, Aqara has opened more than 600 Aqara stores to provide more personalized smart home solutions for individual households and businesses.
Aqara currently serves more than 2 million customers worldwide, with distribution partners in the United States, EU, Russia, Southeast Asia, Korea, and China. The Company also offers one of the most comprehensive suite of HomeKit compatible smart home solutions in the market, and its products can also be found in Apple Stores across Europe and Asia. As the Company continues to expand its global footprint, Aqara hopes to bring more accessible, smart home technology to households around the world.
For more information, please visit our website and follow our social platforms.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211019005028/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 01:00:00 CEST | Press release
-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12 years and older with FOP-Atebrioz expected to be available in the United States in October through Mirum Access Plus (MAP), with eligible patients paying as little as $0 per month-PROGRESS pediatric development program continues to evaluate zilurgisertib in children aged 2 to <12 years Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for pe
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 21:19:00 CEST | Press release
The offtake agreement connects Digital Reef’s 3.3 GW data centre pipeline with environmental assets from more than 30 million hectares of Amazon rainforest across South America, where Oreasoc Agriculture works directly on the ground alongside local communities to develop sustainable economies and safeguard their territories. Xange.com’s digital MRV technology monitors both the data centres and the rainforest. At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where D
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 15:00:00 CEST | Press release
Planned acquisition strengthens NetApp's position in the rapidly growing AI infrastructure market by bringing differentiated metadata innovation and parallel file architecture designed for AI NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata fr
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 14:57:00 CEST | Press release
The Group was recognised for the strength of its global institutional ecosystem and its contribution to financial markets innovation and community impact MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity
Croma-Pharma Introduces saypha® volume prime Lidocaine25.9.2026 14:04:00 CEST | Press release
New cross-linked hyaluronic acid filler replaces saypha® volume Lidocaine, offering physicians a more versatile solution for both midface volumization and nasolabial folds Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom